Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor

MK-2048 represents a prototype second-generation integrase strand transfer inhibitor (INSTI) developed with the goal of retaining activity against viruses containing mutations associated with resistance to first-generation INSTIs, raltegravir (RAL) and elvitegravir (EVG). Here, we report the identif...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bar-Magen, Tamara, Sloan, Richard D., Donahue, Daniel A., Kuhl, Björn D., Zabeida, Alexandra, Xu, Hongtao, Oliveira, Maureen, Hazuda, Daria J., Wainberg, Mark A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2010
Aiheet:
Vaccines and Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2937597/
https://ncbi.nlm.nih.gov/pubmed/20610719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01164-10
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia